{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-038004","form_type":"8-K","ticker":null,"cik":"0001779020","company_name":"Danimer Scientific, Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.493380+00:00","generated_at":"2026-06-04T06:22:25.153289+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Danimer reports FY2023 revenue down 12% to $46.7M; guides FY2024 Adj. EBITDA improvement","bullets":["Q4 revenue $10.9M (-29% YoY); full-year revenue $46.7M vs $53.2M.","Full-year Adj. EBITDA $(39.0)M vs $(45.0)M in 2022; Q4 Adj. EBITDA $(10.7)M.","FY2024 Adj. EBITDA guidance $(22)-(32)M; CapEx $8-10M; expects accelerating H2 growth.","Unrestricted cash $59.2M at Dec 31, 2023; March 2024 equity raise added >$13M.","PHA sales grew 6% YoY; PLA sales declined $6.1M due to Ukraine conflict."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-038004","json":"https://secwatch.observer/filing/0000950170-24-038004.json","markdown":"https://secwatch.observer/filing/0000950170-24-038004.md","text":"https://secwatch.observer/filing/0000950170-24-038004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/0000950170-24-038004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/dnmr-20240328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:22:25.153289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c0a863cfde096f433f74acfefc50b9717d04fb4f","claim":"Danimer Scientific, Inc. updated its fourth quarter and full year ended December 31, 2023 guidance (reaffirmed).","evidence_excerpt":"On March 28, 2024, Danimer Scientific, Inc. (“Danimer”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/0000950170-24-038004-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}